Latest News
Kosmos Energy (KOS) Q3 2026 Earnings Call Transcriptfool.com
Production grew 6% as debt fell $500 million, signaling improved momentum.
Via The Motley Fool · November 3, 2026
Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcriptfool.com
Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.
Via The Motley Fool · November 3, 2026
Tactile (TCMD) Q3 2026 Earnings Call Transcriptfool.com
Lymphedema revenue surged 13% as Medicare prior authorization stabilized.
Via The Motley Fool · November 3, 2026
Ibotta (IBTA) Q3 2026 Earnings Call Transcriptfool.com
Redemption revenue surged 23% as publisher network hit all-time high redeemers.
Via The Motley Fool · November 3, 2026
3 Genius Artificial Intelligence (AI) Stocks to Buy Hand Over Fist Before Year-Endfool.com
While AI and memory stocks get hammered on bubble fears, these three companies just posted sold-out demand, record revenue, and raised guidance.
Via The Motley Fool · November 3, 2026
Match (MTCH) Q3 2026 Earnings Call Transcriptfool.com
Tinder DAU returns to growth after 3.5 years; Hinge revenue surges 19% YoY.
Via The Motley Fool · November 3, 2026
Upwork (UPWK) Q3 2026 Earnings Call Transcriptfool.com
AI initiatives and higher-value clients drive $185.6M revenue amid marketplace pressures.
Via The Motley Fool · November 3, 2026
Ethos (LIFE) Q3 2026 Earnings Call Transcriptfool.com
Record revenue surged 151% year-over-year as both distribution channels scaled rapidly.
Via The Motley Fool · November 3, 2026
SI-BONE (SIBN) Q3 2026 Earnings Call Transcriptfool.com
Procedure volume surged 20% as active physicians hit record 1,770.
Via The Motley Fool · November 3, 2026
Inspire (INSP) Q3 2026 Earnings Call Transcriptfool.com
Reimbursement headwinds cut Q3 revenue, but 2027 outlook improves.
Via The Motley Fool · November 3, 2026
Ichor (ICHR) Q3 2026 Earnings Call Transcriptfool.com
Revenue surged 37% year-over-year as margins expanded and earnings doubled sequentially.
Via The Motley Fool · November 3, 2026
I-Mab Picks Givastomig Dose After Promising Gastric Cancer Data, Aligns With FDAmarketbeat.com
I-Mab (NASDAQ:NBP) presented updated Phase 1b data for givastomig, an investigational treatment being developed for frontline metastatic gastric and gastroesophageal cancer, citing longer follow-up that the company said strengthened its confidence in the therapy’s durability, safety profile and pote
Via MarketBeat · November 3, 2026
Massive News for Salesforce Stock Investorsfool.com
The company is making yet another acquisition.
Via The Motley Fool · November 3, 2026
Fabrinet (FN) Q1 2027 Earnings Call Transcriptfool.com
Data center revenue surged 78% as Fabrinet expands capacity.
Via The Motley Fool · November 2, 2026
Gaia (GAIA) Q3 2026 Earnings Call Transcriptfool.com
Revenue fell 12% as Gaia prioritizes high-value direct subscribers over volume.
Via The Motley Fool · November 2, 2026
Waystar (WAY) Q3 2026 Earnings Call Transcriptfool.com
Subscription bookings surged 34% as AI capabilities drove adoption gains.
Via The Motley Fool · November 2, 2026
Travere (TVTX) Q3 2026 Earnings Call Transcriptfool.com
FILSPARI sales hit $200.2 million as FSGS launches alongside sustained IgAN demand.
Via The Motley Fool · November 2, 2026
Hinge Health (HNGE) Q3 2026 Earnings Call Transcriptfool.com
Revenue surged 52% as operating margins expanded 1,300 basis points year over year.
Via The Motley Fool · November 2, 2026
ON Semiconductor (ON) Q3 2026 Earnings Call Transcriptfool.com
AI data center revenue surged 175% year over year as supply constraints redirected capacity.
Via The Motley Fool · November 2, 2026
Neurocrine (NBIX) Q3 2026 Earnings Call Transcriptfool.com
Record $1.1B revenue marks transformative quarter for diversified biotech.
Via The Motley Fool · November 2, 2026
Harmonic (HLIT) Q3 2026 Earnings Call Transcriptfool.com
Revenue surged 64% as Rest-of-Market segment doubled, signaling customer diversification.
Via The Motley Fool · November 2, 2026
Apple (AAPL) Q4 2026 Earnings Call Transcriptfool.com
Record iPhone and Mac sales drive $114.5B revenue amid supply constraints.
Via The Motley Fool · November 2, 2026
BioMarin (BMRN) Q3 2026 Earnings Call Transcriptfool.com
Revenue topped $1 billion for first time, fueled by Amicus integration.
Via The Motley Fool · November 2, 2026
Allison Transmission (ALSN) Q3 2026 Earnings Call Transcriptfool.com
Legacy transmission business hit record quarterly revenue amid Off-Highway integration.
Via The Motley Fool · November 2, 2026
Syndax (SNDX) Q3 2026 Earnings Call Transcriptfool.com
Revenue surged 82% year-over-year as Revuforj and Niktimvo drive commercial momentum.
Via The Motley Fool · November 2, 2026